apo010
Small moleculeexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2007 (NCT00437736)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- apo010
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03196947 | Phase 1/Phase 2 (Phase 2) | Jun 13, 2017 | Medical Prognosis Institute A/S, Oncology Venture, Smerud Medical Research Denmark, University of Copenhagen |
| NCT00437736 | Phase 1 | Feb 1, 2007 | Ospedale S. Giovanni Bellinzona, Valerio |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medical Prognosis Institute A/S | For profit | 1 | 0 | 1 | 2017 |
| Oncology Venture | For profit | 1 | 1 | 1 | 2017 |
| Ospedale S. Giovanni Bellinzona | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Smerud Medical Research Denmark | For profit | 1 | 0 | 1 | 2017 |
| University of Copenhagen | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Valerio | For profit | 1 | 1 | 1 | 2007 |
6 organizations
Page 1 / 1